African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
Leading African biopharmaceutical company Minapharm Group (www.Minapharm.com), headquartered in Egypt with subsidiaries in Berlin, will receive up to…
New vaccination approach turns mosquito bites into immunity boosters
Researchers from WEHI (Melbourne, Australia) have discovered a new way to help prevent malaria that could one day…
Jiangsu vs Guangdong: why the battle to be China’s No 1 economy is heating up
The southern Guangdong province has been the largest engine powering China’s economic rise for decades. But the region…
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…
Yokogawa and Repligen partner to enhance process analytical technology
Yokogawa Corporation of America and Repligen announce a collaboration to integrate Yokogawa’s OpreX Bio Pilot with Repligen’s MAVERICK®,…
Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics
Labman is proud to be involved in a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing using cutting-edge automation,…